$0.225
-0.029 (-12.96%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VVOS Prediction & Forecast by Similar Chart Analysis
Alphio's VVOS stock price prediction model matches the current Vivos Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (+1.67%). The 1-week path is $0.23 (+1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vivos Therapeutics Inc Stock?
Vivos Therapeutics is not a good buy right now due to significant financial instability and declining stock performance. The current price is $0.22, which has dropped 91.11% year-to-date. Additionally, the RSI is at 21.92, indicating the stock is oversold, but this does not guarantee a reversal. The company faces a widening net loss of $5.5 million in Q2 2026, alongside a cash position of only $1.8 million, which raises concerns about its ability to fund operations in the near term. The main risk is the potential for further equity dilution as analysts suggest significant reinforcement of the balance sheet is needed.
VVOS stock price ended at $0.22 on Friday, after losing -12.96%
Vivos Therapeutics Inc (VVOS) last closed at $0.2249, losing -12.96%. These facts feed the 1-day and 1-week VVOS price prediction above.
Forecast Drivers
Vivos Therapeutics Inc (VVOS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VVOS, ranked by similarity.
Seasonality analysis for VVOS
Historically the probability of a positive August return for VVOS is 28.57%. July offers the highest probability of a positive month at 30.30%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VVOS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.25 | $2.45 | $2.86 | +991.59% |
| Sep 2026 | $2.87 | $2.89 | $3.22 | +1185.87% |
| Oct 2026 | $2.50 | $2.63 | $2.72 | +1067.28% |
| Nov 2026 | $1.79 | $2.11 | $2.53 | +837.94% |
| Dec 2026 | $2.03 | $2.50 | $2.98 | +1011.76% |
In 2026, Vivos Therapeutics Inc (VVOS) is projected to range from $1.79 to $3.22.
Vivos Therapeutics Inc 2026 monthly forecast
In Aug 2026, Vivos Therapeutics Inc is projected to average $2.45, with a low of $2.25 and high of $2.86.
In Sep 2026, Vivos Therapeutics Inc is projected to average $2.89, with a low of $2.87 and high of $3.22.
In Oct 2026, Vivos Therapeutics Inc is projected to average $2.63, with a low of $2.50 and high of $2.72.
In Nov 2026, Vivos Therapeutics Inc is projected to average $2.11, with a low of $1.79 and high of $2.53.
In Dec 2026, Vivos Therapeutics Inc is projected to average $2.50, with a low of $2.03 and high of $2.98.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.